Inflammatory bowel disease among radiographic axial spondyloarthritis’ patients: Frequency and diagnostic value of fecal calprotectin

Ghada A. Ahmed; Fatma M. Aboud; Mohammad M.A. Alsawe; Alshymaa M.F. Motaher

doi:10.1016/j.ejr.2026.01.005

January 28, 2026The Egyptian Rheumatologist

Inflammatory bowel disease among radiographic axial spondyloarthritis’ patients: Frequency and diagnostic value of fecal calprotectin

View at Publisher

Ask AI

Bookmark

Share

Key Points

Fecal calprotectin levels correlate with the presence of inflammatory bowel disease, indicating its diagnostic utility.
Patients with axial spondyloarthritis showed a notable frequency of inflammatory bowel disease diagnosed through fecal calprotectin tests.
Assessment involved comparing fecal calprotectin results against conventional diagnostic criteria for inflammatory bowel disease.
Findings imply that fecal calprotectin can enhance early diagnosis of gastrointestinal complications in axial spondyloarthritis.

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Implication

Observational analysis reveals fecal calprotectin's diagnostic value for inflammatory bowel disease in axial spondyloarthritis patients, suggesting potential for better assessment.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Ahmed et al. (2026) studied this question.

synapsesocial.com/papers/69a75c5dc6e9836116a252f0 https://doi.org/10.1016/j.ejr.2026.01.005

View at Publisher

Ask AI

Bookmark

Share

Inflammatory bowel disease among radiographic axial spondyloarthritis’ patients: Frequency and diagnostic value of fecal calprotectin

Key Points

No abstract yet

Implication

Discussion

Cite This Study

Inflammatory bowel disease among radiographic axial spondyloarthritis’ patients: Frequency and diagnostic value of fecal calprotectin

Key Points

No abstract yet

Implication

Discussion

Cite This Study

Keep reading

Keep reading